SK284914B6 - Deriváty 4a,5a,8a,8b-tetrahydro-6H-pyrolo[3',4':4,5]furo-[3,2-b] pyridín-6,8(7H)-diónu na hubenie endoparazitov a spôsob ich výroby - Google Patents

Deriváty 4a,5a,8a,8b-tetrahydro-6H-pyrolo[3',4':4,5]furo-[3,2-b] pyridín-6,8(7H)-diónu na hubenie endoparazitov a spôsob ich výroby Download PDF

Info

Publication number
SK284914B6
SK284914B6 SK492-98A SK49298A SK284914B6 SK 284914 B6 SK284914 B6 SK 284914B6 SK 49298 A SK49298 A SK 49298A SK 284914 B6 SK284914 B6 SK 284914B6
Authority
SK
Slovakia
Prior art keywords
carbon atoms
group
alkyl
cycloalkyl
formula
Prior art date
Application number
SK492-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK49298A3 (en
Inventor
Peter Jeschke
Achim Harder
Norbert Mencke
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of SK49298A3 publication Critical patent/SK49298A3/sk
Publication of SK284914B6 publication Critical patent/SK284914B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • C07D491/147Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541Non-condensed thiazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SK492-98A 1995-10-19 1996-10-07 Deriváty 4a,5a,8a,8b-tetrahydro-6H-pyrolo[3',4':4,5]furo-[3,2-b] pyridín-6,8(7H)-diónu na hubenie endoparazitov a spôsob ich výroby SK284914B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19538960A DE19538960A1 (de) 1995-10-19 1995-10-19 4a,5a,8a,8b-Tetrahydro-6H-pyrrolo [3',4':4,5] furo [3,2-b] pyridin-6,8(7H)-dion Derivate zur Bekämpfung von Endoparasiten, Verfahren zu ihrer Herstellung
PCT/EP1996/004346 WO1997014695A1 (de) 1995-10-19 1996-10-07 4a,5a,8a,8b-TETRAHYDRO-6H-PYRROLO[3',4':4,5]FURO [3,2-b]PYRIDIN-6,8(7H)-DION DERIVATE ZUR BEKÄMPFUNG VON ENDOPARASITEN UND VERFAHREN ZU IHRER HERSTELLUNG

Publications (2)

Publication Number Publication Date
SK49298A3 SK49298A3 (en) 1998-09-09
SK284914B6 true SK284914B6 (sk) 2006-02-02

Family

ID=7775277

Family Applications (1)

Application Number Title Priority Date Filing Date
SK492-98A SK284914B6 (sk) 1995-10-19 1996-10-07 Deriváty 4a,5a,8a,8b-tetrahydro-6H-pyrolo[3',4':4,5]furo-[3,2-b] pyridín-6,8(7H)-diónu na hubenie endoparazitov a spôsob ich výroby

Country Status (23)

Country Link
US (2) US6110928A (cs)
EP (1) EP0871630B1 (cs)
JP (1) JP4157163B2 (cs)
KR (1) KR100444144B1 (cs)
CN (1) CN1111535C (cs)
AR (1) AR004023A1 (cs)
AT (1) ATE211475T1 (cs)
AU (1) AU706836B2 (cs)
BR (1) BR9611002B1 (cs)
CZ (1) CZ295075B6 (cs)
DE (2) DE19538960A1 (cs)
DK (1) DK0871630T3 (cs)
ES (1) ES2170271T3 (cs)
HU (1) HUP9802854A3 (cs)
NO (1) NO323609B1 (cs)
NZ (1) NZ320174A (cs)
PL (1) PL185960B1 (cs)
PT (1) PT871630E (cs)
SK (1) SK284914B6 (cs)
TR (1) TR199800686T2 (cs)
TW (1) TW466241B (cs)
WO (1) WO1997014695A1 (cs)
ZA (1) ZA968788B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19719839A1 (de) * 1997-05-12 1998-11-19 Bayer Ag 6-Substituierte 1,2,4a,5a,8a,8b-Hexahydro- und 1,2,3,4,4a,5a,8a,8b-Oktahydro-6H-pyrrolo/3',4':4,5/furo/3,2-b/pyrid-8(7H)-on Derivate und ihre Verwendung zur Bekämpfung von Endoparasiten
DE10201544A1 (de) * 2002-01-17 2003-07-31 Bayer Cropscience Ag Substituierte Pyrazoline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4032090A1 (de) * 1990-02-13 1991-08-14 Bayer Ag Polycyclische 3-aryl-pyrrolidin-2,4-dion-derivate
DE4121365A1 (de) * 1991-06-28 1993-01-14 Bayer Ag Substituierte 1-h-3-aryl-pyrrolidin-2,4-dion-derivate

Also Published As

Publication number Publication date
TW466241B (en) 2001-12-01
US6291472B1 (en) 2001-09-18
NZ320174A (en) 2000-12-22
CN1204335A (zh) 1999-01-06
HK1017359A1 (en) 1999-11-19
AU7286596A (en) 1997-05-07
CZ295075B6 (cs) 2005-05-18
HUP9802854A2 (hu) 1999-05-28
DE19538960A1 (de) 1997-04-24
NO323609B1 (no) 2007-06-18
JPH11513675A (ja) 1999-11-24
US6110928A (en) 2000-08-29
DK0871630T3 (da) 2002-04-29
BR9611002B1 (pt) 2010-11-30
WO1997014695A1 (de) 1997-04-24
HUP9802854A3 (en) 2001-12-28
KR100444144B1 (ko) 2005-01-13
NO981502L (no) 1998-04-02
CN1111535C (zh) 2003-06-18
ZA968788B (en) 1996-12-03
EP0871630A1 (de) 1998-10-21
DE59608617D1 (de) 2002-02-28
SK49298A3 (en) 1998-09-09
PL185960B1 (pl) 2003-09-30
CZ118898A3 (cs) 1998-08-12
AU706836B2 (en) 1999-06-24
NO981502D0 (no) 1998-04-02
BR9611002A (pt) 1999-07-13
JP4157163B2 (ja) 2008-09-24
AR004023A1 (es) 1998-09-30
EP0871630B1 (de) 2002-01-02
TR199800686T2 (xx) 1998-07-21
ES2170271T3 (es) 2002-08-01
KR19990063812A (ko) 1999-07-26
PT871630E (pt) 2002-06-28
ATE211475T1 (de) 2002-01-15
PL326323A1 (en) 1998-09-14

Similar Documents

Publication Publication Date Title
EP0973756B1 (de) Thiodepsipeptide zur bekämpfung von endoparasiten und ein verfahren zu ihrer herstellung
JP2010222361A (ja) ジデプシペプチドおよびその殺内部寄生虫薬としての使用
US6291472B1 (en) 4a, 5a, 8a, 8b-tetrahydro-6H-pyrrolo[3′,4′:4, 5]furo[3,2-b] pyri-dine-6,8(7H)-dione derivatives for control of endoparasites processes for their preparation
CA2235017C (en) 4a,5a,8a,8b-tetrahydro-6h-pyrrolo[3,4':4,5]furo(3,2-b)pyridine-6,8[7h]-dione derivatives for use in controlling endoparasites and a method of producing said derivatives
EP0986564B1 (de) 6-substituierte 1,2,4a,5a,8a,8b-hexahydro- und 1,2,3,4,4a,5a,8a,8b-oktahydro-6h-pyrrolo[3',4':4,5]furo[3,2-b]pyrid-8(7h)-on derivate und ihre verwendung zur bekämpfung von endoparasiten
CZ402099A3 (cs) 6-substituované deriváty 1,2,4a,5a,8a,8bhexahydro- a l,2,3,4,4a,5a,8a,8b-oktahydro6H-pyrrolo[3',4':4,5]furo-[3,2-b]pyrid-8(7H)- onu, způsob jejich výroby, endoparasiticidní prostředek tyto látky obsahující a jejich použití
MXPA99010377A (en) 6-SUBSTITUTED 1,2,4a,5a,8a,8b HEXAHYDRO- AND 1,2,3,4,4a,5a,8a, 8b-OCTAHYDRO-6H-PYRROLO [3',4':4,5]FURO[3,2-b]PYRID-8(7H)-ON DERIVATIVES AND THEIR USE IN COMBATTING ENDOPARASITES

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, MONHEIM AM R, DE

Free format text: FORMER OWNER: BAYER ANIMAL HEALTH GMBH, LEVERKUSEN, DE

Effective date: 20121011

MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20121007